Please use this identifier to cite or link to this item: https://doi.org/10.1186/s12879-017-2569-4
DC FieldValue
dc.titleRole of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore
dc.contributor.authorChan, M
dc.contributor.authorOoi, C.K
dc.contributor.authorWong, J
dc.contributor.authorZhong, L
dc.contributor.authorLye, D
dc.date.accessioned2020-10-27T10:23:41Z
dc.date.available2020-10-27T10:23:41Z
dc.date.issued2017
dc.identifier.citationChan, M, Ooi, C.K, Wong, J, Zhong, L, Lye, D (2017). Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore. BMC Infectious Diseases 17 (1) : 474. ScholarBank@NUS Repository. https://doi.org/10.1186/s12879-017-2569-4
dc.identifier.issn14712334
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/181264
dc.description.abstractBackground: Treatment of community acquired skin and soft tissue infections (SSTIs) is a common indication for outpatient parenteral antibiotic therapy (OPAT) in USA, UK and Australasia, however data from Asia are lacking. OPAT is well established within the Singapore healthcare since 2002, however, systematic use of OPAT for the treatment of SSTIs remains infrequent. In this report, we describe the treatment and outcome of patients with SSTIs referred directly from Emergency Department (ED) to OPAT for continuation of intravenous (IV) antibiotics in Singapore, thus avoiding potential hospital admission. Method: This is a single center university hospital retrospective study of patients with SSTIs presenting to ED who were assessed to require IV antibiotics and accepted to the OPAT clinic for continuation of IV treatment. Exclusion criteria were: haemodynamic instability, uncontrolled or serious underlying co-morbidities, necessity for inpatient surgical drainage, facial cellulitis and cephalosporin allergy. Patients returned daily to the hospital's OPAT clinic for administration of IV antibiotics and review, then switched to oral antibiotics on improvement. Results: From 7 February 2012 to 31 July 2015, 120 patients with SSTIs were treated in OPAT. Median age was 56 years and 63% were male. Lower limbs were affected in 91%. Diabetes was present in 20%. Sixty-seven (56%) had been treated with oral antibiotics for a median duration of 3 days prior to OPAT treatment. Common symptoms were erythema (100%), swelling (96%), pain (88%) and fever (55%). Antibiotics administered were IV cefazolin with oral probenecid (71%) or IV ceftriaxone (29%) for median 3 days then oral cloxacillin (85%) for median 7 days. Clinical improvement occurred in 90%. Twelve patients (10%) were hospitalized for worsening cellulitis, with 4 patients requiring surgical drainage of abscess. Microbiological cultures from 2 patients with drained abscess grew methicillin sensitive Staphylococcus aureus (MSSA) and Klebsiella pneumoniae, both of which were susceptible to cefazolin and ceftriaxone. Hospital bed days saved was 318 days. Conclusion: OPAT treatment of community acquired SSTIs in a selected patient population has good outcomes in Singapore. Treatment with IV cefazolin or IV ceftriaxone was successful in the majority with low hospital readmission rate. © 2017 The Author(s).
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceUnpaywall 20201031
dc.subjectamoxicillin plus clavulanic acid
dc.subjectantibiotic agent
dc.subjectcefazolin
dc.subjectceftriaxone
dc.subjectclindamycin
dc.subjectcloxacillin
dc.subjectprobenecid
dc.subjectantiinfective agent
dc.subjectceftriaxone
dc.subjectcloxacillin
dc.subjectabscess drainage
dc.subjectadult
dc.subjectaged
dc.subjectantibiotic sensitivity
dc.subjectantibiotic therapy
dc.subjectArticle
dc.subjectbacterium culture
dc.subjectcellulitis
dc.subjectcommunity acquired infection
dc.subjectcontrolled study
dc.subjectdisease duration
dc.subjectdisease exacerbation
dc.subjectemergency ward
dc.subjecterythema
dc.subjectfemale
dc.subjectfever
dc.subjecthospital readmission
dc.subjecthospitalization
dc.subjecthuman
dc.subjectKlebsiella pneumoniae
dc.subjectlength of stay
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmethicillin susceptible Staphylococcus aureus
dc.subjectnonhuman
dc.subjectoutcome assessment
dc.subjectoutpatient care
dc.subjectpain
dc.subjectpatient referral
dc.subjectpatient selection
dc.subjectretrospective study
dc.subjectSingapore
dc.subjectskin abscess
dc.subjectskin infection
dc.subjectsoft tissue infection
dc.subjectswelling
dc.subjecttreatment duration
dc.subjectuniversity hospital
dc.subjectadolescent
dc.subjectcommunity acquired infection
dc.subjectdrug effects
dc.subjectintravenous drug administration
dc.subjectisolation and purification
dc.subjectmethicillin resistant Staphylococcus aureus
dc.subjectmiddle aged
dc.subjectoutpatient
dc.subjectoutpatient department
dc.subjectskin infection
dc.subjectsoft tissue infection
dc.subjectstaphylococcal skin infection
dc.subjectStaphylococcus infection
dc.subjecttreatment outcome
dc.subjectAdolescent
dc.subjectAdult
dc.subjectAged
dc.subjectAnti-Bacterial Agents
dc.subjectCeftriaxone
dc.subjectCloxacillin
dc.subjectCommunity-Acquired Infections
dc.subjectFemale
dc.subjectHumans
dc.subjectInfusions, Intravenous
dc.subjectMale
dc.subjectMethicillin-Resistant Staphylococcus aureus
dc.subjectMiddle Aged
dc.subjectOutpatient Clinics, Hospital
dc.subjectOutpatients
dc.subjectRetrospective Studies
dc.subjectSingapore
dc.subjectSkin Diseases, Infectious
dc.subjectSoft Tissue Infections
dc.subjectStaphylococcal Infections
dc.subjectStaphylococcal Skin Infections
dc.subjectTreatment Outcome
dc.typeArticle
dc.contributor.departmentMEDICINE
dc.description.doi10.1186/s12879-017-2569-4
dc.description.sourcetitleBMC Infectious Diseases
dc.description.volume17
dc.description.issue1
dc.description.page474
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1186_s12879-017-2569-4.pdf357.28 kBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons